Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 67, 2012 - Issue 1
57
Views
0
CrossRef citations to date
0
Altmetric
Continuing Medical Education

SEVERE INFLUENZA A(H1N1)2009 INFECTION: A SINGLE CENTRE EXPERIENCE AND REVIEW OF THE LITERATURE

, &
Pages 1-6 | Published online: 08 Oct 2014

REFERENCES

  • Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 467–470.
  • Amato-Gauci A, Zucs P. Snacken R, et al. Surveillance trends of the 2009 influ-enza A(H1N1) pandemic in Europe. Euro Surveil' 2011; 16.
  • Influenza A (H1N1)v virus infections in Belgium, May-June 2009. Euro Surveil' 2009; 14: pii=19270.
  • Van Kerkhove MD, Vandemaele KA, Shinde V. et al. Risk Factors for Severe Out-comes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis. PLoS Med 2011; 8: e1001053.
  • European centre for disease Prevention and Control (ECDC). ECDC Risk assess-ment: seasonal influenza 2010–2011 in Europe (EU/EEA countries). 2011.
  • Review of the 2010-2011 winter influenza season, northern hemisphere. Wkly Epidemiol Rec 2011; 86:222–227.
  • Ellis J, Galiano M, Pebody R, et al. Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill 2011; 16 pii=19760.
  • http://influenza.wiv-isp.be/nl/syndromicsurveillance/Pages/default.aspx. 2011.
  • Tang JW, Shetty N, Lam TT. Features of the new pandemic influenza A/H1N1/ 2009 virus: virology, epidemiology, clinical and public health aspects. Curr Opin Pulm Med 2010; 16:235–241.
  • Venkata C, Sampathkumar P,Afessa B. Hospitalized patients with 2009 H1N1 influ-enza infection: the Mayo Clinic experience. Mayo Clin Proc 2010; 85: 798–805.
  • World Health Organisation (WHO). Clinical management of human infections with pandemic (H1N1) 2009: revised guidance. 2009. http://www.who.int/csr/resources/publications/swineflu/clinical_management_h1nl.pdf, World Health Organisation (WHO).
  • Akins PT, Belko J, Uyeki TM, et al. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care 2010;13:396–406.
  • Chacko B, Peter JV, Pichamuthu K, et al. Cardiac manifestations in patients with pandemic (H1N1) 2009 virus infection needing intensive care. J Crit Care 2011 [Epub ahead of print].
  • Estenssoro E, Rios FG, Apezteguia C, et al. Pandemic 2009 influenza A in Argen-tina:a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med 2010; 182: 41–48.
  • Rello J, Rodriguez A, Ibanez P. et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 2009; 13: R148.
  • Riscili BP, Anderson TB, Prescott HC, et al. An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics. PLoS One 2011; 6: e18166.
  • Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010; 38: e91–e97.
  • Jean C, Louie JK, Glaser CA, et al. Invasive group A streptococcal infection con-current with 2009 H1N1 influenza. Clin Infect Dis 2010; 50: e59–e62.
  • Zakikhany K, Degail MA, Lamagni T, et al. Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveil' 2011; 16.
  • Boggild AK, McGeer AJ. Laboratory diagnosis of 2009 H1N1 influenza A virus. Crit Care Med 2010; 38: e38–e42.
  • Aviram G, Bar-Shai A, Sosna J, et al. H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology 2010; 255: 252–259.
  • Cuquemelle E, Soulis F, Villers D, et al. Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study. Intensive Care Med 2011; 37: 796–800.
  • Piacentini E, Sanchez B, Arauzo V. et al. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with commu-nity-acquired bacterial pneumonia. A pilot study. J Crit Care 2011; 26: 201–205.
  • World Health Organisation (WHO). WHO Guidelines for the Pharmacological Management of Pandemic Influenza A (H1N1) 2009 and other influenza Viruses. Part I: Recommendations. 2010. World Health Organisation (WHO).
  • Siston AM, Rasmussen SA, Honein MA, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA 2010; 303: 1517–1525.
  • Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10: 521–526.
  • Choi SM, Boudreault AA, Xie H, et al. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011; 117: 5050–5056.
  • Lee N, Choi KW, Chan PK, et al. Outcomes of adults hospitalised with severe influenza. Thorax 2010; 65: 510–515.
  • Meschi S, Selleri M, Lalle E, et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis 2011; 11: 140.
  • Ljungman P. de la Camara R, Perez-Bercoff L, et al. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 2011;96: 1231–1235.
  • Smith JR, Ariano RE, Toovey S. The use of antiviral agents for the management of severe influenza. Crit Care Med 2010; 38: e43–e51.
  • Martin-Loeches I, Lisboa T, Rhodes A, et al. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011; 37: 272–283.
  • Kim SH, Hong SB, Yun SC, et al. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using pro-pensity scores. Am J Respir Crit Care Med 2011; 183: 1207–1214.
  • Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L. Early corticos-teroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011; 183: 1200–1206.
  • Ramsey CD, Funk D, Miller RR, Ill, Kumar A. Ventilator management for hypox-emic respiratory failure attributable to H1N1 novel swine origin influenza virus. Crit Care Med 2010; 38: e58–e65.
  • Park PK, Napolitano LM, Bartlett RH. Extracorporeal membrane oxygenation in adult acute respiratory distress syndrome. Crit Care Clin 2011; 27: 627–646.
  • Mitchell MD, Mikkelsen ME, Umscheid CA, et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010; 38: 1398–1404.
  • Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised con-trolled trial. Lancet 2009; 374: 1351–1363.
  • Davies A, Jones D, Bailey M, et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302: 1888–1895.
  • Martin-Loeches I, Papiol E, Rodriguez A, et al. Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection. Crit Care 2011; 15: R66.
  • Pettila V, Webb SA, Bailey M, et al. Acute kidney injury in patients with influenza A (H1N1) 2009. Intensive Care Med 2011; 37: 763–767.
  • Akritidis N, Mastora M, Baxevanos G, Dimos G, Pappas G. Electrocardiographic abnormalities in patients with novel H1N1 influenza virus infection. Am J Cardiol 2010; 106: 1517–1519.
  • Beutel G, Wiesner O, Eder M, et al. Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infec-tion. Crit Care 2011; 15: R80.
  • Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis 2008; 14: 95–100.
  • Pierce M, Kurinczuk JJ, Spark P. Brocklehurst P. Knight M. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ 2011; 342: d3214.
  • Mirochnick M, Clarke D. Oseltamivir pharmacokinetics in pregnancy: a com-mentary. Am J Obstet Gynecol 2011; 204: S94–595.
  • Nair P. Davies AR, Beca J, et al. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med 2011; 37: 648–654.
  • Poehling KA, Szilagyi PG, Staat MA, et al. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol 2011; 204: S141–5148
  • Cordero E, Perez-Romero P. Moreno A, et al. Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clin Microbiol Infect 2011 [Epub ahead of print].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.